Compare Definium Therapeutics Inc. Common Shares (DFTX) vs JFrog Ltd. Ordinary Shares (FROG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs JFrog Ltd. Ordinary Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while JFrog Ltd. Ordinary Shares trades at $97.61 (market cap $12.10B). The key difference: JFrog Ltd. Ordinary Shares is far larger — about 2.6× Definium Therapeutics Inc. Common Shares's market cap, and JFrog Ltd. Ordinary Shares is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and JFrog Ltd. Ordinary Shares for 0 Days on average.
| DFTX | FROG | |
|---|---|---|
Market Cap | $4.71B | $12.10B |
Volume | 1,966,636 | 773,694 |
Sector | Health | Technology |
52-Week High | $48.45 | $104.03 |
52-Week Low | $10.68 | $34.75 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $11.29B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About JFrog Ltd. Ordinary Shares
JFrog provides software supply chain tools that help developers manage, secure, and distribute software packages. Its platform is used across development and deployment workflows.
Read more on FROG →
